close_game
close_game

usfda

Latest from usfda

US drug body approves 1st over-the-counter opioid overdose reversal drug Narcan

Naloxone rapidly reverses or blocks the effects of opioids, restoring normal respiration, especially when given within minutes of the first signs of an overdose.

The overdose-reversal drug Narcan is displayed.(AP)
Published on Mar 29, 2023 07:10 PM IST
Reuters |

Tamil Nadu firm told to suspend eye drops’ manufacturing

The manufacturers were directed to “stop the manufacturing activities of all the products under the category of ophthalmic preparations till the completion of investigation”, the report added.

Tamil Nadu’s Drug Controller and members from the CDSCO carried out an inspection of the Chennai-based Global Pharma Healthcare from 7pm on Friday to 2am on Saturday. (ANI)
Updated on Feb 05, 2023 09:28 AM IST
BySoumya Pillai and Divya Chandrababu, New Delhi/chennai

US approves new antibody treatment -- for arthritic cats

These lab-grown proteins have grabbed headlines during the pandemic for preventing high-risk people with Covid from getting severely ill.

Overall, the cats in the treatment group had better assessment scores than those who received placebos during randomized clinical trials.(AFP)
Published on Jan 14, 2022 03:17 AM IST
AFP |

J&J vaccine gets additional warning on bleeding aide effect

J&J vaccines has been accused of causing serious blood clots and compelling a rare bleeding disorder. 

J&J said in a statement that “individuals who have been previously diagnosed with ITP should talk to their health-care provider regarding the risk of ITP and the potential need for platelet monitoring following vaccination.”(MINT_PRINT)
Published on Jan 13, 2022 10:56 AM IST
Bloomberg | , Usa

ChemoCentryx's avacopan, used to treat rare autoimmune disease, gets approval

The disease affects about 40,000 people in the United States, with about 4,000 new cases each year, according to the company.

US health agency approved avacopan, which will be available under brand name Tavneos in the next few weeks, will have a wholesale price of between $150,000 and $200,000 per patient per year. (Reuters)
Published on Oct 08, 2021 10:42 PM IST
Reuters |
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, May 09, 2025
Follow Us On